Navigation Links
Angiotech and Rex Medical announce exclusive licensing and distribution agreement for the "Option(TM)" inferior vena cava filter
Date:3/13/2008

nt.getElementById('headline'); s.tl(this,'o',getLinkName('Company Sanpshot'));" >ANPI, TSX: ANP), please visit http://www.angiotech.com.

About Rex Medical, LP

Rex Medical, LP, based in Conshohocken, PA, is a privately held medical device company specializing in the development, manufacturing and marketing of minimally invasive medical devices targeted towards the cardiovascular, venous access, endosurgery and oncology markets.

FORWARD-LOOKING STATEMENTS:

Statements contained in this press release that are not based on historical fact, including without limitation statements containing the words "believes," "may," "plans," "will," "estimate," "continue," "anticipates," "intends," "expects" and similar expressions, constitute "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 and constitute "forward-looking information" within the meaning of applicable Canadian securities laws. All such statements are made pursuant to the "safe harbor" provisions of applicable securities legislation. Forward-looking statements may involve, but are not limited to, comments with respect to our strategies or future actions, our targets, expectations for our financial condition and the results of, or outlook for, our operations, research development and product and drug development. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, events or developments to be materially different from any future results, events or developments expressed or implied by such forward-looking statements. Many such risks, uncertainties and other factors are taken into account as part of our assumptions underlying these forward-looking statements and include, among others, the following: general economic and business conditions, both nationally and in the regions in which we operate; market
'/>"/>

SOURCE Angiotech Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Angiotech showcases its Hemostream(TM) Dialysis Catheter at the Society of Interventional Radiology (SIR) Annual Meeting
2. Angiotech announces results for the fourth quarter ended December 31, 2007
3. Angiotech to participate in Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
4. Angiotech Pharmaceuticals, Inc. - Notice of Conference Call and Webcast
5. Angiotech and Symphony Medical Announce Licensing Agreement
6. Athersys and Angiotech announce authorization of Phase I intramyocardial stem cell U.S. clinical trial in acute myocardial infarction
7. Angiotech Submits 510(K) To FDA For Its Innovative 5-FU CVC
8. Angiotech to participate in RBC 2007 Healthcare Conference
9. Angiotech to participate in Bank of America 2007 Credit Conference
10. Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook
11. Angiotech Receives CE Mark Approval of Quill(TM) SRS MONODERM(TM), a New Rapidly Resorbing Suture Product Line
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... overlooked factor in the medical application of nanoparticles. ... on both radiofrequency heating and magnetic resonance image ... including detailed analysis of the aggregate morphologies based ... produce significant reductions in both heating and MRI ... quantify and correlate these effects for clinical applications, ...
(Date:9/2/2014)... 2, 2014 Persistence Market Research ... in Pharmaceutical, Biopharma and Life Sciences: North ... the global membrane technology market for pharmaceutical, biopharma and life sciences ... is expected to grow at a CAGR of 9.1% ... of USD 10,886.0 million in 2019. Browse ...
(Date:9/2/2014)... Sept. 2, 2014 Orexigen Therapeutics, Inc. (Nasdaq: ... Patent and Trademark Office (PTO) has issued a patent ... for weight loss. NB32 is a fixed-dose combination of ... U.S. Patent No. 8,815,889 claims methods for treating insulin ... patent expires in 2024. If NB32 is approved for ...
(Date:9/2/2014)... Mount, NC (PRWEB) September 02, 2014 ... establishment of its 11th clinical research site: PMG Research ... assumed ownership and operation of the clinical research department ... further expanding PMG’s presence in eastern North Carolina. This ... patients. For the patients in Rocky Mount and the ...
Breaking Biology Technology:Accounting for biological aggregation in heating and imaging of magnetic nanoparticles 2Global Membrane Technology Market Will Reach $10,886.0 Million in 2019: Persistence Market Research 2Global Membrane Technology Market Will Reach $10,886.0 Million in 2019: Persistence Market Research 3Global Membrane Technology Market Will Reach $10,886.0 Million in 2019: Persistence Market Research 4Global Membrane Technology Market Will Reach $10,886.0 Million in 2019: Persistence Market Research 5Orexigen Expands NB32 Intellectual Property Portfolio With New U.S. Patent 2Orexigen Expands NB32 Intellectual Property Portfolio With New U.S. Patent 3Orexigen Expands NB32 Intellectual Property Portfolio With New U.S. Patent 4PMG Research Announces the Formation of its Eleventh Site 2PMG Research Announces the Formation of its Eleventh Site 3
... Wis . - Can a heart patient's own stem cells be ... School of Medicine and Public Health intends to find out ... Hospital and Clinics . , ,The school is among the first ... which will investigate whether a person's own stem cells can treat ...
... - Deltanoid Pharmaceuticals , a privately held pharmaceutical ... clinical study of 2MD, its lead osteoporosis compound. , ... can safely improve bone mineral density in postmenopausal women. ... bone that results in susceptibility to fractures, occurs frequently ...
... - In a recent report that probably went ... University Technology Managers released figures that show why ... Wisconsin is a hotbed for scientific research. The numbers ... professors working in labs; it's about creating jobs for ...
Cached Biology Technology:UW tests adult stem cell role in regenerative heart care 2Tapping hidden assets: Wisconsin researchers who can create jobs 2Tapping hidden assets: Wisconsin researchers who can create jobs 3Tapping hidden assets: Wisconsin researchers who can create jobs 4
(Date:9/2/2014)... Human Genetics (ASHG) and the National Human Genome ... of Health, have named Elizabeth P. Tuck, MA, ... in Columbus, Ohio, the first ASHG/NHGRI Genetics and ... The Genetics and Education Fellowship is intended to ... and network to prepare for a career in ...
(Date:9/2/2014)... -- A team of University of Maryland physicists ... other scientists say make possible new nanostructures and ... energy and quantum computing advances to new sensor ... of Nature Communications the Maryland scientists, ... for hybrid nanostructures that uses a connector, or ...
(Date:9/2/2014)... new study that could ultimately lead to many new ... Research Institute (TSRI) have adapted a chemical approach to ... that can treat a form of muscular dystrophy. , ... a disease-causing defect as a catalyst to synthesize a ... Disney.,"Because the treatment is synthesized only in diseased cells, ...
Breaking Biology News(10 mins):ASHG and NHGRI award first genetics and education fellowship 2New synthesis method may shape future of nanostructures, clean energy 2New synthesis method may shape future of nanostructures, clean energy 3Scripps Florida scientists make diseased cells synthesize their own drug 2
... More atomic hydrogen gas the ultimate fuel for stars ... astronomer Dr Robert Braun has found.,This is the first accurate ... Just after the Big Bang the Universe,s matter was ... came together and generated galaxies, stars and planets and ...
... Agricultural Research and Development, have evaluated the effect of ... in sheep flocks. This disease mainly causes abortions, although ... and weakness in newborn lambs. The control of this ... it spreads easily among the animals and causes significant ...
... be held in Copenhagen, Denmark, on 4-5 June, ... the GMES Global Monitoring for Environment and Security ... User testimonials of pre-operational services, prospects for increased ... assessments will form the core of the conference ...
Cached Biology News:There's more star-stuff out there but it's not dark matter 2The effect of treatment with antibiotics and vaccination against Q fever in sheep 2The effect of treatment with antibiotics and vaccination against Q fever in sheep 3
... is a simple, easy to use ... bacterial and yeast applications. The ... voltages and either one mm, two ... pressing the pulse button the electroporator ...
... CGH Genomic Labeling Systems are a high-performance ... genomic DNA samples for array-based Comparative Genomic ... direct labeling formats, the BioPrime Plus Array ... solution to your genomic labeling needs. ...
MOUSE ANTI GTP BINDING PROTEIN...
The Cellject Elecroporator is suitable for all cell types including embryo, mammalian, plant, yeast and bacterial. Its has highly user-freindly programing and can be used remotely, for example in a l...
Biology Products: